Canadian Biotech Stock Powers Higher on Distribution Deal

StageZero Life Sciences, Ltd (TSX:SZLS), a Canadian biotech stock, jumped after its licensing partner signed a multi-year agreement with BodyCheck NL

Sean Mason | October 11, 2019 | SmallCapPower

A multi-year distribution and sales agreement lifted a Canadian biotech stock Friday. Here’s some small stocks making big moves on Friday, October 11, 2019 (as of 4:00 pm EST):

StageZero Life Sciences, Ltd (TSX:SZLS), a Canadian biotech stock, continued to move higher Friday, up 14% to $0.12 following a 31% gain on Thursday, after announcing that its licensing partner, Oncore Pharma, has signed a multi-year agreement with BodyCheck NL for the distribution and sale of ColonSentry throughout the Netherlands, Belgium and Luxembourg.

Win Big With Our Small Cap Picks


As well, shares of MTY Food Group Inc. (TSX:MTY) slipped 9% to $57.75 as the franchisor and operator of quick-service and casual dining restaurants said its third-quarter revenue rose 44% to $163.1 million, yet same-store sales for the quarter increased by just 0.3% compared to the same period last year.

Sonoro Energy Ltd. (TSXV:SNV), meanwhile, reported that it expects to sign the Selat Panjang Production Sharing Contract with the Indonesian Ministry of Energy on October 14, 2019. Sonoro Energy stock moved up 33% to $0.16 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: